About Next Healthcare

Scientific Advisory Board

  • Curt Civin M.D.

    Curt Civin M.D. serves as Associate Dean for Research, Director of the Center for Stem Cell Biology & Regenerative Medicine, and Professor of Pediatrics and Physiology of the University of Maryland School of Medicine. Prior to this, he spent a highly successful 30 year tenure at Johns Hopkins Medical School primarily focused on Pediatrics and Oncology as endowed professor and leader. Dr. Civin's pioneering research discoveries include the identification and isolation of CD34+ blood-forming stem-progenitor cells, which dramatically improved stem cell research and led to improved stem cell transplantation for thousands of patients. Dr. Civin's research is focused on the cell and molecular biology of the stem and progenitor cells that form the normal blood and immune systems, and the malignant counterparts of these stem-progenitor cells, the leukemias. Currently, Dr. Civin's lab seeks to understand how the survival, proliferation, and differentiation of normal and malignant stem-progenitor cells are regulated. In basic studies, the Civin lab has comprehensively described which genes, and recently microRNAs, are active and functional in human hematopoietic stem-progenitor cells, using microarrays and amplification strategies. The lab's mission is to translate the resulting understanding and tools to clinical use. Dr. Civin earned a B.A. from Amherst College, and an M.D. cum laude, from Harvard Medical School. He completed Pediatric residency training at Boston Children's Hospital and a fellowship in Pediatric Hematology-Oncology at the National Cancer Institute.

    Participation by Dr. Civin as an advisor does not constitute or imply endorsement by the University of Maryland, Baltimore, University System of Maryland or the University of Maryland Medical System.

  • Chandan Sen, Ph.D.

    Chandan Sen, Ph.D. is a tenured Professor of Surgery and the Executive Director of the Ohio State University Comprehensive Wound Center. He is also the Associate Dean for Research at The Ohio State University Medical Center. After completing his Masters of Science in Human Physiology from the University of Calcutta, Dr. Sen received his PhD in Physiology from the University of Kuopio in Finland. Dr. Sen trained as a postdoctoral fellow at the University of California at Berkeley's Molecular and Cell Biology department. His first faculty appointment was in the Lawrence Berkeley National Laboratory in California. In fall of 2000, Dr. Sen moved to the Ohio State University where he established a program on tissue injury and repair. Currently, Dr. Sen is a Professor and Vice Chair of Research of Surgery. His research program is housed in the Davis Heart and Lung Research Institute where he serves as a Deputy Director and the Director of the Regenerative Medicine Program. Dr. Sen's current research on tissue injury and repair is split into three programs: stroke, post-infarction myocardial remodeling and cutaneous wound healing. He is a PI of several projects including four clinical trials.

    Dr. Sen is a widely recognized expert in redox and oxygen biology. He is the author of the most cited work in tocotrienol. He is the Editor-in-Chief of the #1 rated journal in redox biology Antioxidants & Redox Signaling (impact factor 8.209). He is also an Associate Editor of the prestigious American Physiological Society journal Physiology Genomics. He is the Editor-in-Chief of the Wound Healing Society's yearbook Advances in Wound Care. Dr. Sen has published over 250 publications and is cited over 900 times a year in the literature.

    Participation by Dr. Sen as an advisor does not constitute or imply endorsement by the Ohio State University or its Medical Center. Relationship of Dr. Sen with NextHealthCare Inc is subject to the policies of The Ohio State University related to the management of Conflict of Interest.

Terms of ServicePrivacy Policy

Copyright © 2016 Next Heathcare, Inc. - All Rights Reserved

Website Designed and Powered by Delmarva Group